The Royal Australian and New Zealand College of Ophthalmologists (RANZCO) New Zealand branch has issued a position statement with strategies to address the country’s “fractured” diabetic retinopathy (DR) screening programme.
Enrolments have commenced for Kiora Pharmaceuticals KIO-201 eyedrop phase 2 trial. Designed to accelerate natural corneal wound healing in patients with persistent corneal epithelial defect (PCED),
The majority of New Zealanders living with diabetes have experienced potential symptoms of diabetic retinopathy (DR), yet many of them had never heard of it, new research has revealed.
Belgian startup Morrow has added Zeiss Ventures to its list of backers, which have collectively invested more than €25m (NZ$40.7m) to help bring its liquid crystal display (LCD) auto-focusing spectacles to market.
The World Council of Optometry (WCO) and Alcon have engaged international dry eye specialists, Professors James Wolffsohn (Aston University, UK), Jennifer Craig (Auckland University, New Zealand) and Lyndon Jones (Waterloo University, Canada) to develop education tools for eyecare practitioners acro
Despite Covid and the lack of face-to-face meeting opportunities, the fifth workshop of the Tear Film and Ocular Surface Society (TFOS) is proceeding apace with the aim of submitting the final report early next year for assessment and then release, said chair Professor Jennifer Craig.
Glaucoma New Zealand (GNZ) is raising awareness of glaucoma’s impact on mental health in the lead up to Mental Health Awareness Week, from 26 September to 2 October. According to GNZ, an estimated
Canadian pop star Justin Bieber is suffering facial paralysis on one side of his face and has been diagnosed with Ramsay Hunt syndrome. In a short Instagram video, Bieber demonstrated that he can only smile, nostril-twitch and blink on one side of his face. The singer said he is optimistic he will m
A Chinese study has revealed a significant correlation between dry eye disease (DED) and anxiety and depression, with researchers proposing sleep quality acts as a mediator between the conditions.
A sequence-randomised, double-masked, vehicle-controlled crossover clinical trial of Aldeyra’s 0.25% reproxalap ophthalmic solution have shown it was statistically superior to placebo for both primary endpoints of ocular redness in a dry eye chamber and Schirmer test after a single day of dosing.
An Austrian phase 2 study showed topical oestradiol reduced signs and symptoms of dry eye disease (DED) in postmenopausal women for at least three months.
Researchers have found Japanese teenagers with high myopia reported significantly more dryness, less photophobia and less pain than those with no myopia.
